Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) EBITDA Margin (2024 - 2025)

Historic EBITDA Margin for Rallybio (RLYB) over the last 2 years, with Q3 2025 value amounting to 7558.02%.

  • Rallybio's EBITDA Margin rose 113125300.0% to 7558.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 2243.73%, marking a year-over-year increase of 88927200.0%. This contributed to the annual value of 9620.33% for FY2024, which is N/A changed from last year.
  • Per Rallybio's latest filing, its EBITDA Margin stood at 7558.02% for Q3 2025, which was up 113125300.0% from 4591.04% recorded in Q2 2025.
  • Rallybio's 5-year EBITDA Margin high stood at 7558.02% for Q3 2025, and its period low was 557250.0% during Q4 2024.